Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to …

AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan… - Vaccines, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …

Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines

A Fara, Z Mitrev, RA Rosalia, BM Assas - Open biology, 2020 - royalsocietypublishing.org
Coronavirus disease 2019 (COVID-19) has swept the world, unlike any other pandemic in
the last 50 years. Our understanding of the disease has evolved rapidly since the outbreak; …

Microenvironment‐Activated Nanozyme‐Armed Bacteriophages Efficiently Combat Bacterial Infection

L Jin, F Cao, Y Gao, C Zhang, Z Qian… - Advanced …, 2023 - Wiley Online Library
Bacterial infection is one of the greatest challenges to public health, requiring new
therapeutic methods. Herein, an innovative nanozyme‐armed phage (phage@ palladium …

Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2

Y Gu, J Cao, X Zhang, H Gao, Y Wang, J Wang, J He… - Cell research, 2022 - nature.com
Host cellular receptors play key roles in the determination of virus tropism and pathogenesis.
However, little is known about SARS-CoV-2 host receptors with the exception of ACE2 …

Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation

J Chen, Q Jiang, X Xia, K Liu, Z Yu, W Tao, W Gong… - Aging cell, 2020 - Wiley Online Library
The COVID‐19 coronavirus is now spreading worldwide. Its pathogen, SARS‐CoV‐2, has
been shown to use angiotensin‐converting enzyme 2 (ACE2) as its host cell receptor, same …

[HTML][HTML] Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of …

TP Vogel, KA Top, C Karatzios, DC Hilmers, LI Tapia… - Vaccine, 2021 - Elsevier
Abstract This is a Brighton Collaboration Case Definition of the term “Multisystem
Inflammatory Syndrome in Children and Adults (MIS-C/A)” to be utilized in the evaluation of …

Pharmaco-immunomodulatory therapy in COVID-19

JG Rizk, K Kalantar-Zadeh, MR Mehra, CJ Lavie… - Drugs, 2020 - Springer
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Y Rodríguez, L Novelli, M Rojas, M De Santis… - Journal of …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has been categorized as evolving in
overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the …

[HTML][HTML] Caring for patients with cancer in the COVID-19 era

J van de Haar, LR Hoes, CE Coles, K Seamon… - Nature medicine, 2020 - nature.com
The current COVID-19 pandemic challenges oncologists to profoundly re-organize
oncological care in order to dramatically reduce hospital visits and admissions and therapy …

Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential …

A Jafarzadeh, P Chauhan, B Saha, S Jafarzadeh… - Life sciences, 2020 - Elsevier
Abstract The COVID-19-, SARS-and MERS-related coronaviruses share many genomic and
structural similarities. However, the SARS-CoV-2 is less pathogenic than SARS-CoV and …